Aion Therapeutic Ownership
| ANTCF Stock | USD 0.01 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Aion |
Aion Pink Sheet Ownership Analysis
About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.04. Aion Therapeutic had not issued any dividends in recent years. Aion Therapeutic Inc., a pharmaceutical company, offer medical cannabis products in Canada. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada. Aion Therapeutic is traded on OTC Exchange in the United States.The quote for Aion Therapeutic is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Aion Therapeutic please contact Graham Simmonds at 416 460 3000 or go to https://www.aiontherapeutic.com.Currently Active Assets on Macroaxis
Other Information on Investing in Aion Pink Sheet
Aion Therapeutic financial ratios help investors to determine whether Aion Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aion with respect to the benefits of owning Aion Therapeutic security.